Antitumor Effects of Quercetin and Luteolin in MeWo Melanoma Cells: Potential Association with GPER Signaling

Abstract Introduction with high mortality rate, cutaneous melanoma (CM) is considered the most dangerous form of skin cancer, with steadily increasing incidence worldwide. Hormone-related therapies, especially those involving estrogen (E2), have emerged as promising strategies for treating CM. The phytoestrogens quercetin and luteolin have gained attention due to their antitumor effects across various cancers, including melanoma. However, the precise mechanisms by which they exert their effects and their association with G-protein-coupled estrogen receptor (GPER) signaling in melanoma remain unclear. Methods we investigated the inhibitory effects of quercetin and luteolin in the MeWo melanoma cell line and their modulation of GPER-associated signaling. The effects of the flavonoids on cell viability, apoptosis and cell cycle were examined by MTT assay and flow cytometry. Cell migration was evaluated by transwell assay. GPER expression was verified by immunofluorescence staining, and the impact of the flavonoids on key signaling proteins was confirmed by Western blot. Results we showed that quercetin and luteolin exerted anti-proliferative and anti-migratory effects in melanoma cells. The two flavonoids also induced apoptosis and arrested the cell cycle at S and G2/M phases. Immunofluorescence and immunoblotting confirmed the presence of GPER in this cell line, and treatment with quercetin and luteolin, particularly at 100 µM, upregulated its expression. Quercetin and luteolin, as well as the GPER agonist G-1, enhanced the expression of P-ERK and c-Myc but reduced the expression of P-Akt. These responses were attenuated or reversed by the specific GPER antagonist G15, supporting a potential association between these effects and GPER signaling. Conclusion quercetin and luteolin have antitumor effects on the MeWo melanoma cell line in association with GPER signaling, suggesting that GPER-associated pathways are associated with their anti-melanoma effects and warrant further investigation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-10-29
DOI
https://doi.org/10.21203/rs.3.rs-11524807/v1
Primary Topic
Flavonoids in Medical Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Antitumor Effects of Quercetin and Luteolin in MeWo Melanoma Cells: Potential Association with GPER Signaling

Shtaywy Abdalla, Abdullah Awidi, Nidaa A. Ababneh, Noor Tarawneh et al.
1 links
Research Square
Flavonoids in Medical Research
preprint

Antitumor Effects of Quercetin and Luteolin in MeWo Melanoma Cells: Potential Association with GPER Signaling

Shtaywy Abdalla, Abdullah Awidi, Nidaa A. Ababneh, Noor Tarawneh, Shaimaa Hussein
preprint en

Abstract

Abstract Introduction with high mortality rate, cutaneous melanoma (CM) is considered the most dangerous form of skin cancer, with steadily increasing incidence worldwide. Hormone-related therapies, especially those involving estrogen (E2), have emerged as promising strategies for treating CM. The phytoestrogens quercetin and luteolin have gained attention due to their antitumor effects across various cancers, including melanoma. However, the precise mechanisms by which they exert their effects and their association with G-protein-coupled estrogen receptor (GPER) signaling in melanoma remain unclear. Methods we investigated the inhibitory effects of quercetin and luteolin in the MeWo melanoma cell line and their modulation of GPER-associated signaling. The effects of the flavonoids on cell viability, apoptosis and cell cycle were examined by MTT assay and flow cytometry. Cell migration was evaluated by transwell assay. GPER expression was verified by immunofluorescence staining, and the impact of the flavonoids on key signaling proteins was confirmed by Western blot. Results we showed that quercetin and luteolin exerted anti-proliferative and anti-migratory effects in melanoma cells. The two flavonoids also induced apoptosis and arrested the cell cycle at S and G2/M phases. Immunofluorescence and immunoblotting confirmed the presence of GPER in this cell line, and treatment with quercetin and luteolin, particularly at 100 µM, upregulated its expression. Quercetin and luteolin, as well as the GPER agonist G-1, enhanced the expression of P-ERK and c-Myc but reduced the expression of P-Akt. These responses were attenuated or reversed by the specific GPER antagonist G15, supporting a potential association between these effects and GPER signaling. Conclusion quercetin and luteolin have antitumor effects on the MeWo melanoma cell line in association with GPER signaling, suggesting that GPER-associated pathways are associated with their anti-melanoma effects and warrant further investigation.

Research Square
University of Jordan (JO), Al-Zaytoonah University of Jordan (JO)
University of Jordan
Good health and well-being
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon